Association between HLA-DR Expression and Multidrug-resistant Infection in Patients with Severe Acute Pancreatitis.

Yu, Zhu-Xi; Chen, Xian-Cheng; Zhang, Bei-Yuan; Liu, Ning; Gu, Qin

Yu, Zhu-Xi; Chen, Xian-Cheng; Zhang, Bei-Yuan; Liu, Ning; Gu, Qin.

Afiliação

Yu ZX; Department of Critical Care Medicine, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Chen XC; Department of Critical Care Medicine, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Zhang BY; Department of Critical Care Medicine, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Liu N; Department of Critical Care Medicine, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Gu Q; Department of Critical Care Medicine, the Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, 210008, China. guqin-icul@yeah.net.

Curr Med Sci ; 38(3): 449-454, 2018 Jun.

Article em En | MEDLINE | ID: mdl-30074211

Assuntos

Farmacorresistência Bacteriana Múltipla; Antígenos HLA-DR/metabolismo; Pancreatite/metabolismo; Doença Aguda; Adulto; Relação CD4-CD8; Demografia; Feminino; Humanos; Células Matadoras Naturais/imunologia; Masculino; Pessoa de Meia-Idade; Pancreatite/sangue; Pancreatite/imunologia; Pancreatite/microbiologia

Palavras-chave

human leukocyte antigen-antigen D-related (HLA-DR); immunomonitoring; multidrug-resistant infection; severe acute pancreatitis (SAP)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pancreatite / Antígenos HLA-DR / Farmacorresistência Bacteriana Múltipla Tipo de estudo: Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Revista: Curr Med Sci Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google